| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ryan Fischer, Pat Furlong, Annie Kennedy, Kelly Maynard, Marissa Penrod, Debra Miller, Chamindra G Laverty, Linda P Lowes, Nancy L Kuntz, Perry B Shieh, Jane Kondejewski, Peter J Neumann, Jason Shafrin, Richard J Willk. Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies. Journal of multidisciplinary healthcare. vol 17. 2024-09-03. PMID:39224484. |
traditional value assessment frameworks are challenged in comprehensively assessing the societal value new therapies bring to individuals with rare, progressive, genetic, fatal, neuromuscular diseases such as duchenne muscular dystrophy (dmd). |
2024-09-03 |
2024-09-05 |
Not clear |
| Alexa C Klimchak, Lauren E Sedita, Eleanor M Perfetto, Katherine L Gooch, Daniel C Malon. Discriminatory properties of QALY-based CEA for patients with disabilities: A Duchenne muscular dystrophy case study. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2024-08-02. PMID:39094692. |
this study examined the impact of a qaly-based assessment on the price for a hypothetical treatment for duchenne muscular dystrophy (dmd), a progressive, genetic neuromuscular disease. |
2024-08-02 |
2024-08-06 |
Not clear |
| Hitham Aldhare. Duchenne muscular dystrophy in Saudi Arabia: a review of the current literature. Frontiers in neurology. vol 15. 2024-08-01. PMID:39087004. |
dmd is a rare, severe neuromuscular disease that causes death due to cardiovascular and respiratory complications among affected boys. |
2024-08-01 |
2024-08-03 |
Not clear |
| Shivam Gandhi, H Lee Sweeney, Cora C Hart, Renzhi Han, Christopher G R Perr. Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response. Cells. vol 13. issue 14. 2024-07-26. PMID:39056750. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease caused by mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of myofiber integrity in skeletal and cardiac muscle, and eventual cell death and replacement with fibrotic tissue. |
2024-07-26 |
2024-07-28 |
Not clear |
| Kalina Andrysiak, Paweł E Ferdek, Anna M Sanetra, Gabriela Machaj, Luisa Schmidt, Izabela Kraszewska, Katarzyna Sarad, Katarzyna Palus-Chramiec, Olga Lis, Marta Targosz-Korecka, Marcus Krüger, Marian H Lewandowski, Guillem Ylla, Jacek Stępniewski, Józef Dula. Upregulation of utrophin improves the phenotype of Duchenne muscular dystrophy hiPSC-derived CMs. Molecular therapy. Nucleic acids. vol 35. issue 3. 2024-07-22. PMID:39035791. |
duchenne muscular dystrophy (dmd) is a genetic neuromuscular disease. |
2024-07-22 |
2024-07-24 |
human |
| Rebecca Delaney, Ken D O'Hallora. Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models. Experimental physiology. 2024-07-18. PMID:39023735. |
duchenne muscular dystrophy (dmd) is a fatal genetic neuromuscular disease. |
2024-07-18 |
2024-07-20 |
mouse |
| Camille Verebi, Victor Gravrand, Thierry Bienvenu, France Leturcq, Juliette Nectou. A retrospective cohort study and review of the literature about germline mosaicism in Duchenne/Becker muscular dystrophy prenatal counseling: How to estimate the recurrence risk in clinical settings? Journal of genetic counseling. 2024-06-19. PMID:38895972. |
duchenne muscular dystrophy (dmd) and becker muscular dystrophy (bmd) are the most common inherited neuromuscular diseases. |
2024-06-19 |
2024-06-21 |
Not clear |
| b' Chantal A Coles, Keryn G Woodman, Elizabeth M Gibbs, Rachelle H Crosbie, Jason D White, Shireen R Lamand\\xc3\\xa. Benfotiamine improves dystrophic pathology and exercise capacity in mdx mice by reducing inflammation and fibrosis. Human molecular genetics. 2024-05-06. PMID:38710523.' |
duchenne muscular dystrophy (dmd) is a progressive and fatal neuromuscular disease. |
2024-05-06 |
2024-05-27 |
mouse |
| Christina Qian, Alexa C Klimchak, Shelagh M Szabo, Evan Popoff, Susan T Iannaccone, Katherine L Gooc. Observing the Clinical Course of Duchenne Muscular Dystrophy in Medicaid Real-World Healthcare Data. Advances in therapy. 2024-05-02. PMID:38698169. |
duchenne muscular dystrophy (dmd) is a rare, severe progressive neuromuscular disease. |
2024-05-02 |
2024-05-05 |
Not clear |
| Kay E Davies, Julie Vog. Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene. Neuromuscular disorders : NMD. vol 39. 2024-04-23. PMID:38653179. |
duchenne muscular dystrophy is a neuromuscular disease caused by dmd gene mutations that result in an absence of functional dystrophin protein. |
2024-04-23 |
2024-04-26 |
Not clear |
| Craig M Zaidman, Natalie L Goedeker, Amal A Aqul, Russell J Butterfield, Anne M Connolly, Ronald G Crystal, Kara E Godwin, Kan N Hor, Katherine D Mathews, Crystal M Proud, Elizabeth Kula Smyth, Aravindhan Veerapandiyan, Paul B Watkins, Jerry R Mendel. Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy. Journal of neuromuscular diseases. 2024-04-12. PMID:38607761. |
duchenne muscular dystrophy (dmd) is a rare, degenerative, recessive x-linked neuromuscular disease. |
2024-04-12 |
2024-04-15 |
Not clear |
| Rose Mary Ferreira Lisboa da Silva, Nathalia Mussi Monteze, Juliana Gurgel Giannetti, Zilda Maria Alves Meir. Electrocardiographic and Autonomic Nervous System Changes after Changes in the Posture of Children and Adolescents with Duchenne Muscular Dystrophy. Arquivos brasileiros de cardiologia. vol 121. issue 2. 2024-04-10. PMID:38597534. |
duchenne muscular dystrophy (dmd) is a rare inherited neuromuscular disease. |
2024-04-10 |
2024-04-12 |
Not clear |
| Simone Nava, Giorgio Conte, Fabio M Triulzi, Giacomo P Comi, Francesca Magri, Daniele Velardo, Claudia M Cinnant. Diffusion tensor imaging reveals subclinical alterations in muscles of patients with becker muscular dystrophy. The British journal of radiology. 2024-04-04. PMID:38574384. |
becker muscular dystrophy (bmd) is a relatively less investigated neuromuscular disease, partially overlapping the phenotype of duchenne dystrophy (dmd). |
2024-04-04 |
2024-04-07 |
Not clear |
| Vahid Omarmeli, Kai-Uwe Lewandrovski, Marjan Assefi, Hanieh Faizmahdavi, Alireza Sharafshah, Nasrin Mansour. A Novel Mutation (Lys31Arg) in the DMD Gene Impacts on Neuromuscular Dysfunctions found by Whole Exome Sequencing and In Silico Analyses in an Iranian Family. Current aging science. 2024-01-24. PMID:38265407. |
duchene muscular disorder (dmd) is a severe x-linked recessive neuromuscular disease. |
2024-01-24 |
2024-01-26 |
Not clear |
| Ying Chen, Chenjie Ling, Mengting Chen, Liqiang Yu, Jing Yang, Qi Fan. Astaxanthin Ameliorates Worsened Muscle Dysfunction of MDX Mice Fed with a High-Fat Diet through Reducing Lipotoxicity and Regulating Gut Microbiota. Nutrients. vol 16. issue 1. 2024-01-11. PMID:38201863. |
duchenne muscular dystrophy (dmd), a severe x-linked inherited neuromuscular disease, has a high prevalence of obesity. |
2024-01-11 |
2024-01-13 |
mouse |
| Tsukasa Tominari, Masaru Takatoya, Toshiya Matsubara, Michio Matsunobe, Daichi Arai, Chiho Matsumoto, Michiko Hirata, Shosei Yoshinouchi, Chisato Miyaura, Yoshifumi Itoh, Hirofumi Komaki, Shin'ichi Takeda, Yoshitsugu Aoki, Masaki Inad. Establishment of a Triple Quadrupole HPLC-MS Quantitation Method for Dystrophin Protein in Mouse and Human Skeletal Muscle. International journal of molecular sciences. vol 25. issue 1. 2024-01-11. PMID:38203473. |
duchenne muscular dystrophy (dmd) is the most common type of neuromuscular disease caused by mutations in the |
2024-01-11 |
2024-01-13 |
mouse |
| Erik Landfeldt, Kim Phung, Farasat Zaman, Eva Åström, Sophia Abner, Hanns Lochmüller, Thomas Sejersen, Leanne M War. Bisphosphonates in Glucocorticoid-Treated Patients With Duchenne Muscular Dystrophy. Neurology. vol 102. issue 2. 2024-01-02. PMID:38165327. |
bisphosphonates are routinely used to treat osteoporosis in patients with duchenne muscular dystrophy (dmd), a rare, severely debilitating neuromuscular disease. |
2024-01-02 |
2024-01-05 |
Not clear |
| Victoria Brown, Elizabeth Merikle, Kelly Johnston, Katherine Gooch, Ivana Audhya, Linda Lowe. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective. Journal of patient-reported outcomes. vol 7. issue 1. 2023-12-12. PMID:38085412. |
duchenne muscular dystrophy (dmd) is a rare, severe, fatal neuromuscular disease characterized by progressive atrophy and muscle weakness, resulting in loss of ambulation, decreased upper body function, and impaired cardiorespiratory function. |
2023-12-12 |
2023-12-17 |
Not clear |
| Dalya Al-Mfarej, Jennifer M Vojtech, Serge H Roy, Elise Townsend, Julie J Keysor, Nancy Kuntz, Vamshi Rao, Joshua C Kline, Bhawna Shiwan. A Virtual Reality Exergame: Clinician-Guided Breathing and Relaxation for Children with Muscular Dystrophy. 2023 IEEE Conference on Virtual Reality and 3D User Interfaces Abstracts and Workshops (VRW). vol 2023. 2023-11-27. PMID:38009078. |
dmd is a rare neuromuscular disease that leads to respiratory muscle dysfunction with anxiety being a common comorbidity. |
2023-11-27 |
2023-11-28 |
human |
| María Rosa Baeza-Barragán, Maria Teresa Labajos Manzanares, Mercedes Cristina Amaya-Álvarez, Fabián Morales Vega, Judit Rodriguez Ruiz, Rocío Martín-Valer. Effectiveness of a 5-Week Virtual Reality Telerehabilitation Program for Children With Duchenne and Becker Muscular Dystrophy: Prospective Quasi-Experimental Study. JMIR serious games. vol 11. 2023-11-22. PMID:37990809. |
duchenne muscular dystrophy (dmd) and becker muscular dystrophy (bmd) are neuromuscular diseases. |
2023-11-22 |
2023-11-29 |
Not clear |